Comer, Sandra D.

Polydrug abuse: a review of opioid and benzodiazepine combination use

Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 703

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial

Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 348

Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep

Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes

Cannabis and Cannabinoid ResearchHIV/AIDS drug development and treatment

Cited by 184

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 175

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy

Greenwald, M. K., Comer, S. D., & Fiellin, D. A. (2014) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 174

Bupropion SR worsens mood during marijuana withdrawal in humans

Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology

Cannabis and Cannabinoid ResearchSmoking Behavior and Cessation

Cited by 135

Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers

Haney, M., Cooper, Z. D., Bedi, G., Herrmann, E., Comer, S. D., Reed, S. C., Foltin, R. W., & Levin, F. R. (2019) · Addiction Biology

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 31

Amphetamine self-administration by humans: modulation by contingencies associated with task performance

Comer, S. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1996) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 26

Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial

Nunes, E. V., Comer, S. D., Lofwall, M. R., Walsh, S. L., Peterson, S., Tiberg, F., Hjelmstrom, P., & Budilovsky-Kelley, N. R. (2024) · JAMA Network Open

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 25

Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids

Nielsen, S., Silva, J. P., Jones, J. D., Krotulski, A., Poovendran, D., Muzangizi, D., Forte, G., White, J., & Comer, S. D. (2026) · Drug and Alcohol Review

Opioid Use Disorder TreatmentForensic Toxicology and Drug Analysis

Cited by 6